BI-639667 | BI 639667: Antagonist of CCR1
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
CCR1
  • IC50:5.4 nM
  • IC50:24 nM
  • IC50:2.4 nM
  • IC50:9 nM
Antagonist
100 nM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: Selectivity over other measured CCRs >1,000-fold. In Cerep panel o ...

Potency
Cellular
In Vitro

CCR1

Mode of Action: Antagonist

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1016/j.bmcl.2018.12.024

In Vivo Validations

Rat
Dose:
Plasma half life: 1.9 h
Systemic clearance: 13% QH
Bioavailability: 10%
Volume of Distribution at Steady-State: 1.1 L/Kg

DOI Reference: 10.1016/j.bmcl.2018.12.024

Dog
Dose:
Plasma half life: 6.9 h
Systemic clearance: 5.8% QH
Bioavailability: 29%
Volume of Distribution at Steady-State: 0.7 L/Kg

DOI Reference: 10.1016/j.bmcl.2018.12.024

Monkey (Cynomolgus)
Dose:
Plasma half life: 4.4 h
Systemic clearance: 17% QH
Bioavailability: 35%
Volume of Distribution at Steady-State: 1.9 L/Kg

DOI Reference: 10.1016/j.bmcl.2018.12.024

Negative Control Compounds

BI 9307
Notes: CCR1 (Ca2+ flux) >3000 nM; Clean GPCR scan

Chemical Information

Molecular Formula C22H18FN5O3S
SMILEs CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1
InChI InChI=1S/C22H18FN5O3S/c1-32(30,31)20-10-14(6-9-25-20)22(7-8-22)27-21(29)18-11-24-13-19-17(18)12-26-28(19)16-4-2-15(23)3-5-16/h2-6,9-13H,7-8H2,1H3,(H,27,29)
Molecular weight 451.11 Da
AlogP 2.7772000000000006
HBond acceptors 8
HBond donors 1
Atoms 50

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 15 Feb 2022)
Cellular Use Rating
In Model Organisms
(The reviewer did not leave any public comments)
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria